Screener
Agios Pharmaceuticals AGIO Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized; 75,821,241 shares issued and 59,604,830 outstanding at June 30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at December 31, 2025 | 76 | 75 |
| Additional paid-in capital | 2,591,745 | 2,555,037 |
| Accumulated other comprehensive (loss) income | (1,795) | 2,193 |
| Accumulated deficit | (761,519) | (561,705) |
| Treasury stock, at cost (16,216,411 shares at June 30, 2026 and December 31, 2025) | (802,486) | (802,486) |
| Total stockholders’ equity | 1,026,021 | 1,193,114 |
| Total liabilities and stockholders’ equity | $1,108,424 | $1,297,225 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's total liabilities & equity?
- Agios Pharmaceuticals (AGIO) reported total liabilities & equity of $1.11B in Q2 2026.
- How has Agios Pharmaceuticals's total liabilities & equity changed year-over-year?
- Agios Pharmaceuticals's total liabilities & equity decreased by 24.7% year-over-year, from $1.47B to $1.11B.
- What is the long-term trend for Agios Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total liabilities & equity has grown at a 8.7% compound annual growth rate (CAGR), from $852.95M to $1.3B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Agios Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude